KateMurray

About Kate Murray

This author has not yet filled in any details.
So far Kate Murray has created 92 blog entries.

Meg Hill

Challenging Assumptions and Living a Good Life with Mito

Meg Hill, 24, lives in St. Albert, Alta., near Edmonton. She has her own apartment, which she shares with her five-year-old tabby cat, Aria. Her boyfriend, Noah, joins her on the weekends. She loves working out, singing in her kitchen, and dancing. She’s close with her family, including her parents, older sister, and two younger sisters, and enjoys hanging out with her friends and watching movies.

Meg is proud of her independence and has a friendly, upbeat demeanour. But she faces daily challenges that many 20-somethings could never relate to.

Diagnosed with mitochondrial complex I deficiency at age 12, Meg has used wheelchairs and walkers since she was a little girl. “My childhood was a lot of doctors’ appointments and a lot of hospital visits and a lot of tests, just figuring out what I had,” she says.

“My parents first started to get worried because I wasn’t developing at the speed that a ‘normal’ kid would,” says Meg. “I wasn’t developing my walking or my speech very well. It took a long time for me to be able to properly learn to walk. I remember feeling so frustrated, how I kept falling. And it was causing me a lot of pain.”

As doctors searched for answers, Meg underwent more and more testing. She was  diagnosed with autism, which she did have but which didn’t explain all of her symptoms or their progression.

“Nobody could figure out what it was,” says Meg. “It took a long time and a lot of people trying to figure out what it was. I knew that hospital like the back of my hand.”

Living with mitochondrial disease, Meg faces daily challenges that include fluctuating pain and balance issues.

“I can wake up one day and be on top of the world,” she says. “I’ll be feeling great, cleaning my house and cooking and doing everything. And then the next day, I can wake up and I’ll be in so much pain that I can’t even get out of bed. It really depends on the day.”

Doing a lot of walking or going for a swim can make the next day excruciating for Meg. She does her best to adapt — going out for short walks around the lake behind her apartment complex, making meal replacement shakes when cooking is too painful, and carefully planning her activities and her bodybuilding workouts around how they might affect her the next day.

“Still, it makes me upset sometimes because I can’t do the things I’ve wanted to do,” she says. She recently had to leave her job as an online grocery assistant at Walmart because it was causing her too much pain. “I was really upset about that,” she says.

Meg uses her walker and wheelchair to conserve her energy and not push her body too hard, but doing so comes with its own challenges.

“I’ve been bullied a lot for using equipment and I’ve been called names and slurs that are meant to be toward disabled people,” she says. “I wish people would not just look at me and assume that I can’t do something or assume that I’m less of a person because of the way I walk or talk or because I’m using equipment. I want people to understand that I’m more than just a disabled person and I’m more than just the equipment I use.”

Meg recalls having coaches kick her out of clubs and being fired from jobs. “People didn’t think that I was a good fit just because I’m ‘disabled’ or because I’m using a walker or wheelchair,” she says.

A lack of awareness has led to many upsetting situations for Meg over the years. From having the police called on her and being drug tested because she was walking unsteadily, to being regularly approached by strangers with their intrusive questions, to having people try to take her equipment or push her in her wheelchair without permission, the experiences undermine Meg’s sense of independence.

“I’m a very independent person,” she says. “It makes me very upset when people don’t believe me when I say I can do this on my own.”

These experiences also make Meg reluctant to use her mobility aids. “It has led me to be scared of using my equipment, because I don’t want to get those stares and questions from people,” she says.

Meg’s family, her boyfriend, and a best friend who has been there for her through everything help her to stay positive and to keep smiling.

“My family make me really happy,” she says. “My sisters and I are really close. My youngest sister lives across the street from me and my one sister also has the same condition as I do. Because of that, I feel like we really understand each other and we can really lift each other up.”

Meg wishes there were more awareness and understanding of mito, and that more people knew that a cancelled plan wasn’t personal. She often keeps her symptoms to herself, hiding the extent of her pain and fatigue, and appreciates people who check in on her.

“It makes me feel special and it makes me feel seen,” she says. “I wish more people would ask me, ‘Hey, how are you feeling today? How are you doing today? Have you eaten?’ Those sorts of questions make me feel good and make me feel like somebody actually cares.”

Meg has come so far since her initial diagnosis. “I remember feeling so scared when I got the diagnosis because I didn’t know what it meant or what was going to happen,” she says. “I wish that I knew that at age 24, I would be living alone, I would be taking care of my own cat, I would be living a good life, and that there was
nothing to be scared of.”

Looking forward, Meg hopes to find a good job (maybe a receptionist or work-from-home position), move in with her partner, and get a bigger place and perhaps a second cat. “I have a really good life right now and I see that only getting better,” she says.

© MitoCanada 2026. Shared with permission. Not for reuse or adaptation without consent.

Antioxidants and Creatine to Support Mitochondrial Function in LHON Cells

Science moves fastest when everyone can take part. That’s why MitoCanada is committed to empowering our community with knowledge. By translating cutting-edge mitochondrial research into clear, easy-to-understand summaries, we aim to nurture curiosity, strengthen understanding, and build confidence in the science driving hope and progress.

Lay Summary: Antioxidants and Creatine to Support Mitochondrial Function in LHON Cells

Authors: Donald Xhuti, Alessandra Chiarot, Mahek Minhas, Samantha Tobia, Nicoletta de Maat, Katherine Manta, Sean Y. Ng, Mark A. Tarnopolsky, Joshua P. Nederveen

What’s this research about?

Leber Hereditary Optic Neuropathy (LHON) is a rare mitochondrial disease that causes sudden, painless loss of central vision. Most cases are caused by mutations in mitochondrial DNA that affect Complex I, one of the key components of the cell’s energy-producing machinery. Additionally, Complex I is also the site of mitochondrial free radical production. Free radicals are unstable molecules produced during normal cell processes, including energy production in mitochondria. When too many free radicals build up, they can damage cells and contribute to oxidative stress. 

In a dysfunctional mitochondrion, such as in the example of an LHON-affected cell, these free radicals far exceed levels the cell can handle; they build up and start damaging cellular components within the cell, including DNA, proteins, membranes and other mitochondria within the cell. Idebenone is a small molecule that helps LHON-affected mitochondria produce less free radicals. However, while idebenone has helped thousands of patients worldwide, and currently is the only approved disease-specific treatment for LHON in several countries, not everyone responds to it, and researchers are actively searching for additional therapies that may help a broader range of patients. 

In this study, researchers from McMaster University investigated whether a combination of readily available supplements, including creatine, CoQ10, alpha-lipoic acid, and vitamin E, could improve mitochondrial function in cells taken from people with LHON. They called this combination treatment ACT (Antioxidant and Creatine Treatment). The team wanted to understand both the common biological problems shared across different LHON mutations and whether this supplement combination could help address them. 

Why is this important?

Although LHON is caused by mutations in mitochondrial DNA, not all patients experience the disease in the same way. Different mutations can lead to different levels of disease severity, and even people with the same mutation may have different outcomes. This makes it challenging to develop treatments that work for everyone. 

The only approved treatment, idebenone, also has limitations. Recent research has shown that its effectiveness depends partly on the presence of a protein called NQO1, which helps activate the drug. Some people naturally have genetic variants that lead to low levels of this protein, meaning idebenone may not work as well for them, and can actually increase oxidative stress (a state when the body produces more free radicals than cells can manage and keep under control). Oxidative stress is an important factor in the development and progression of LHON. This highlights the need for additional treatment options that could benefit people regardless of their genetic background. 

Finding therapies that can reduce oxidative stress from free radicals, improve energy production, and support mitochondrial health could potentially benefit many people living with LHON and may provide insights that extend to other mitochondrial diseases as well. 

How did they study this?

The researchers collected skin biopsies from people with LHON carrying three different mitochondrial DNA mutations. From these samples, they grew fibroblasts, cells commonly used in laboratory research to study mitochondrial function. These cells were compared with fibroblasts from healthy individuals of similar age and sex. 

First, the team carefully examined the mitochondrial health of the LHON cells. They measured how well the mitochondria were working, including energy production, levels of reactive oxygen species- oxygen containing molecules naturally produced by cells that can contribute to cell damage when too many build up. The researchers also looked at how efficiently cells remove and recycle damaged proteins and mitochondria through a process called autophagy. 

Next, they treated the cells with either idebenone or the ACT supplement combination. The ACT formula (containing creatine, CoQ10, alpha-lipoic acid, and vitamin E) was based upon earlier work by Dr. Tarnopolsky’s group showing that this combination lowered oxidative stress and lactate in patients with MELAS, CPEO and LHON in a clinical trial. The researchers then evaluated how the treatments affected mitochondrial function, resistance to cellular stress, oxidative damage, and autophagy. 

What did they find?

The researchers discovered that despite differences between mutations, LHON cells shared several common mitochondrial problems. Compared to healthy cells, they produced higher levels of reactive oxygen species, had impaired energy production, and showed abnormalities in autophagy- the cells clean-up and recycling process. Specifically, LHON cells showed signs of a stalled process of autophagy; although the cells could still package damaged proteins and mitochondria into cellular “garbage bins,” a slower removal process led to a greater build-up of waste. 

When the cells were treated with the ACT combination, several positive changes occurred. The treatment reduced oxidative stress, improved mitochondrial respiration (how mitochondria convert nutrients and oxygen into cellular energy), increased the cells’ ability to withstand environmental stressors, and helped “speed up” autophagy, normalizing it to levels seen in healthy cells. In many cases, the improvements were equal to those seen with idebenone. For some outcomes, the ACT supplement combination performed even better. 

One particularly important finding was that ACT worked independently of NQO1 protein levels. While idebenone’s effectiveness appeared closely linked to the amount of NQO1 protein present in the cells, the benefits of ACT did not depend on NQO1. This suggests the supplement combination could potentially be effective in individuals who may not respond optimally to idebenone due to genetic variants in the NQO1 gene. 

The researchers also found that repeated ACT treatment reduced markers of oxidative stress, increased the energy producing units of the mitochondria and overall improved the efficiency of energy production, by promoting the removal of damaged mitochondria, and helping normalize the cellular systems that maintain healthy mitochondria, such as autophagy. 

What does this mean for mitochondrial disease research?

This study provides evidence that several mitochondrial problems seen in LHON, including oxidative stress, impaired energy production, and disrupted mitochondrial quality control, may be addressed through a multi-ingredient supplement approach. 

Importantly, the research also highlights that mitochondrial diseases involve more than simply reduced energy production. The investigators found that defects in autophagy appear to play an important role in LHON. Understanding these pathways may open new directions for future therapies. 

Because the treatment improved mitochondrial function across multiple LHON mutations and did not rely on NQO1 protein activity, the findings suggest that broader treatment strategies targeting mitochondrial health may have value in genetically diverse patient populations. Although these experiments were conducted in patient-derived cells in the laboratory, the same combination of supplements lowered oxidative stress and lactate in patients with MELAS, CPEO and LHON in a randomized human clinical trial and have been available in Ontario for patients with primary mitochondrial disease for over 20 years though the Inherited Metabolic Disease program. 

In simple terms, what is this study about?

Researchers took cells from people with LHON and tested whether a combination of common mitochondrial-supporting supplements could improve how those cells functioned. They found that the treatment reduced harmful oxidative stress, helped the cells produce energy more effectively, and improved some of the cellular processes that keep mitochondria healthy. In many cases, the results were similar, or superior, to those seen with idebenone, the current approved treatment for LHON, but without Idebenone’s limited applicability to all patients.

Why does this matter to the MitoCommunity?

Many people living with mitochondrial disease are interested in nutritional and supplement-based approaches that may support mitochondrial health. In this study, researchers from McMaster University investigated whether a laboratory-prepared combination of readily available supplements, including creatine, CoQ10, alpha-lipoic acid, and vitamin E, could improve mitochondrial function in cells taken from people with LHON.

The findings are especially encouraging because the treatment appeared to work across multiple LHON mutations and did not depend on the NQO1 protein levels, a factor that can influence response to idebenone. For families affected by LHON, this research offers another avenue worth exploring in future clinical studies and reinforces the importance of targeting mitochondrial health from multiple angles.

Perhaps most importantly, this study reminds us that even when a disease is caused by a genetic mutation, researchers can still look for ways to strengthen the cell’s resilience, improve mitochondrial function, and help cells better cope with stress. Those approaches may ultimately complement future gene-based therapies and contribute to better outcomes for people living with mitochondrial disease.

Real-World Impact: A MitoCommunity Member’s Perspective

LHON Community Member, Andrea Boland, shares her thoughts on this research

“The new findings from the team at McMaster University are genuinely encouraging. As someone affected by LHON, I find positive research incredibly meaningful. I would be interested in trying the ACT supplement combination to see if it could make any difference in my vision. With no options currently available to improve or cure LHON once affected, the opportunity to try something new brings a sense of hope, even while understanding that nothing might change.

When I first started losing vision in my right eye, which was the first to be affected, followed by my left eye a few months later, I took Idebenone daily but I didn’t notice any difference or slowdown in my vision loss. Living with LHON means holding on to every possibility, however small, that something might help. That is why these findings mean so much to me. The chance to try an alternative approach and see whether the results could be better offers something I haven’t had much of since losing my sight.

These findings also give me hope for the future, not only for people who may be affected by LHON but also for those who carry the gene and live with the uncertainty of what might happen. I know how frightening it can be to lose your vision and how profoundly it changes your life. Research like this reminds me that progress is possible, even when it feels slow. It makes me feel like there’s a light at the end of the tunnel, even if it might not be that bright yet. For those of us living with LHON, that little bit of light means more than people might realize.”

Acknowledgment

This MitoInsights article is based on research carried out at McMaster University by Donald Xhuti, Dr. Joshua P. Nederveen, and Dr. Mark A. Tarnopolsky, and colleagues Alessandra Chiarot, Mahek Minhas, Samantha Tobia, Nicoletta de Maat, Katherine Manta, and Sean Y. Ng at McMaster University. Their work helps deepen our understanding of mitochondrial dysfunction in Leber Hereditary Optic Neuropathy (LHON) and explores new approaches to support mitochondrial health.

This MitoInsights was reviewed and approved by a member of or members of this publications authorship.

© MitoCanada 2026. Not for adaptation without consent.

Attributions

Image Credit & Attribution

MitoCanada uses images, illustrations, icons, and design elements across our website to help make information more welcoming, accessible, and engaging for our community.

Some of the images and design elements used on this website have been created or adapted through Canva using MitoCanada’s Canva Pro account. Canva’s licensing terms allow licensed users to use eligible Canva content in their designs, subject to Canva’s Content License Agreement and related terms.

Where ever possible, MitoCanada uses original photography, partner-provided images, publicly available media, and images shared with permission by members of our community.

We make every effort to use images responsibly and in accordance with applicable licensing terms, permissions, and attribution requirements. If an image requires attribution, we will provide credit on this page, directly near the image, or in another appropriate location.

Community and Original Photography

MitoCanada values the use of authentic images that reflect the community we serve. Where possible, we use original photography or photos shared directly by community members, families, volunteers, partners, and event participants with permission.

These images help us represent the lived experiences, relationships, and community connections at the heart of our work.

Questions About Image Use

If you are a rights holder and believe an image on our website has been used incorrectly, please contact us so we can review the concern promptly.

Please include:

  • the webpage URL where the image appears
  • a screenshot or description of the image
  • information about the claimed rights holder
  • any relevant licensing or ownership details

We take image rights seriously and will review concerns in good faith. Where appropriate, we will update attribution, provide additional licensing information, replace the image, or remove it.

Website Attribution

Research

  • Image of lab, ©SolisImages from Getty Images Pro via Canva.com
  • Image of lab research, ©Shironosov from Getty Images via Canva.com
  • Image of mitochondria, ©science photo library via Canva.com
  • Image of research and development ©SolStock from Getty Images Signature via Canva.com
  • Image untitled ©puneetyadava from pixabay via Canva.com
  • Image of medical professionals meeting at conference table ©aliadel from Creoles via Canva.com
  • Image of students holding Canadian flag ©Kate_sept2004 from Getty Images Signature via Canva.com
  • Image of group of studens with Canadian flags in classroom ©pixel shot via Canva.com
  • Image of man looking up and remembering, ©Antonio Diaz from Getty Images via Canva.com
  • Image of woman at computer laptop at kitchen thinking about question, confused idea, ©AaronAmat from Getty Images Pro via Canva.com
  • Image of Community Registration Booth, @Caleb Oquendo from Pexels via Canva.com
  • Image of upset woman talks with mental health professional ©SDI Productions from Getty Images Signature via Canva.com
  • Image of beautiful woman with cancer smiles ©FatCamera from Getty Images Signature via Canva.com
  • Image of woman sitting in armchair and staring at nothing ©halpoint via Canva.com
  • Image of woman receiving IV drip treatment ©FatCamera from Getty Images Signature via Canva.com
  • Image of volvox algae under microscope ©TrueCreatives via Canva.com
  • Image of microscopic research or IVF concept ©nevodka from Getty Images via Canva.com
  • Image of multi-generational family ©elebeZoom from Getty Images via Canva.com
  • Image of Ottawa cityscape, ©rabbit75_ist from Getty Images via Canva.com

Education

  • Image of woman exercising on green yoga mat, ©charliepix via Canva.com
  • Image of woman eating salad ©Monkey Busienss Images via Canva.com
  • Image of woman preparing healthy meal ©fcafotodigital from Getty Images Signature via Canva.com
  • Image of senior man preparing meal in kitchen ©MachineHeadz from Getty Images Signature via Canva.com
  • Image of woman pouring glass of water ©Africa Images via Canva.com
  • Image of apple banana smoothie raw healthy breatfast ©Dannko from Getty Images via Canva.com
  • Image of woman suffering from stomach ache alone ©perfect wave via Canva.com
  • Image of hungry lady holding empty plate ©Nzewi Confidence from Nzewi Confidence’s Images via Canva.com
  • Image of man taking supplements ©Jayson_lys from Getty Images Signature via Canva.com
  • Image of meal prep containers salmon ©carlofranco from Getty Images Signature via Canva.com
  • Image of woman eating granola bar ©Africa Images via Canva.com
  • Image of nutritionist consulting on healthy food choices ©Nuttopong punna from nuttapong punna’s images via Canva.com
  • Image of couple buying online at home ©nortonrsx from Getty Images via Canva.com
  • Image of woman on computer home office ©Hirurg from Getty Images Signature via Canva.com
  • Image of doctor talking to patient in hallway ©nomadsoulphotos via Canva.com
  • Image of happy girl eating vegetables ©oksun70 from Getty Images via Canva.com
  • Image of young woman in office working on computer
  • Image of teacher in classroom ©Truecreatives from Truecreatives via Canva.com
  • Image of smiling teacher in classroom ©martin-dm from Getty Images Signature via Canva.com
  • Image of confident teacher ©Valerii Honcharuk via Canva.com
  • Image of teacher giving lesson near interactive board ©Africa Images via Canva.com
  • Image of students inside classroom ©Arthur Krijgsman from Pexels via Canva.com
  • Image of video conference virtual meeting asian man laptop ©golubovy from Getty Images via Canva.com
  • Image of african american girl using laptop ©luliia Zavalishina from Getty Images via Canva.com

Support

  • Image of newborn baby ©Traida from Getty Images via Canva.com
  • Image of newborn baby first bath ©timnewman from Getty Images Signature via Canva.com
  • Image of happy family portriat ©triloks from Getty Images Signature via Canva.com

Content Use & Collaboration

Our Commitment to Stewardship

At MitoCanada, the stories, images, and resources we share are grounded in the lived experiences of individuals and families, and in collaboration with clinicians and researchers across Canada and beyond.

This content is shared with us through trust and partnership. We carry a responsibility to ensure it is used with care, respect, and integrity.

We are stewards of the content entrusted to us, whether it reflects a personal story, a research partnership, or an educational resource.

This means:

  • Respecting how stories and contributions are shared and represented
  • Ensuring individuals, families, and collaborators remain informed about how content is used
  • Protecting the context, voice, and intent behind each contribution
  • Upholding accuracy and integrity in research-informed content

This approach is central to how we honour the generosity and collaboration of our community and partners.

Scope of Content

This guidance applies to all MitoCanada content, including but not limited to:

  • Faces of Mito and other patient storytelling initiatives (e.g., 15 Stories for 15 Years)
  • MitoInsights and research translation content developed with researcher partners
  • Educational resources, guides, and infographics
  • Images, graphics, and digital assets shared across our platforms

Use of MitoCanada Content

All MitoCanada content is the property of MitoCanada and/or its contributors and collaborators and is protected by copyright.

Content may not be:

  • Reproduced, adapted, or modified without written permission from MitoCanada
  • Rebranded or presented as originating from another organization
  • Shared publicly without appropriate attribution and prior approval

Requesting Permission

We welcome opportunities to collaborate and amplify community voices and research in a way that is thoughtful and respectful.

If you are interested in sharing or using MitoCanada content, please contact us in advance. This allows us to:

  • Confirm consent with individuals and families, where applicable
  • Align with research partners on appropriate use and representation
  • Ensure content is shared accurately, respectfully, and in the right context

To start a conversation, please contact: communications@mitocanada.org

Our Approach to Collaboration

We believe collaboration strengthens awareness, education, and impact across the mitochondrial disease community.

Meaningful collaboration is built on:

  • Transparency and open communication
  • Respect for ownership, contribution, and consent
  • A shared commitment to centring patient and family voices
  • Integrity in representing research and lived experience

We are always open to working together in ways that align with these values.

A Note on Trust

Every story, insight, and resource shared through MitoCanada reflects a contribution from someone who has placed their trust in us.

Protecting that trust is not only a responsibility, it is a commitment we uphold in every partnership, every collaboration, and every piece of content we share.

MitoRevolution Community Interest Form

Thank you for your interest in MitoRevolution

This initiative brings together patient, family and community perspectives across a wide range of health areas, including primary mitochondrial disease, to help inform MitoRevolution’s research, engagement and education efforts.

​We welcome individuals with lived experience, caregivers, and advocates from diverse communities. Please share a few details below so we can better understand your interest and how you’d like to connect with us and get involved.

Privacy note: The information you provide will be used by MitoCanada and the MitoRevolution team to share engagement opportunities with you, based on your expressed interest. Your information will be handled in accordance with applicable privacy standards, including the Personal Health Information Protection Act (PHIPA).

Meet Alyson

Meet Alyson

Meet Louise

Meet Louise

Meet Hazel

Meet Hazel

My name is Hazel Currie, and I’m proud to be involved as a MitoAmbassador. Supporting Canadians living with mito diseases is such important work and so needed. I am active with MitoCanada, supporting the organization through various fundraising and educational events, including “Hazel’s Light Up for Mito” annual walk, Mermaids for Mito, and MitoSpin in my hometown of Victoria, British Columbia. 

I believe that creating connections are key to a healthy and vibrant community. As a professional communicator in my work, I see first-hand the rewards of meaningful engagement and relationship building.

I am diagnosed with the ultra-rare mitochondrial disease, MNGIE (mitochondrial neurogastrointestinal encephalopathy). I want to educate and share with others about mito diseases, be part of creating awareness, and hopefully find better treatments and a cure. There are days I just want to curse MNGIE & its effects.

My vision is finding other MNGIE patients in Canada and around the world, so those with rare diseases know they are not alone.

I aim to lead an active lifestyle, embracing challenging hikes and walks with my husband and sons. I also enjoy cooking, reading, doing ocean dips at the beach year-round (rain, shine, or snow!), and hanging out with my affectionate dog and cat.

Meet Keith

Meet Keith

Meet Kailey

Go to Top